Medtronic Vitatron digital pacemakers:
This article was originally published in Clinica
Executive Summary
Medtronic has received US market approval for its Vitatron T-series of digital pacemakers. Digital technology enables the T-series devices to collect heart rate information more quickly and precisely than other pacemakers, the company claimed. This can help physicians better understand the patient's heart condition and confidently apply appropriate pacemaker and drug therapies, the company claimed. The efficiency gains of digital data collection also contribute to the T-series' expected long lifespan of 9.3 years. The devices were developed by Medtronic's European subsidiary, Vitatron.